Nova Mentis Life Science Corp.: Nova Mentis Provides Corporate Update and 2023 Outlook

Vancouver, British Columbia--(Newsfile Corp. - April 5, 2023) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global leader

Related Keywords

Vancouver ,British Columbia ,Canada ,Toronto ,Ontario ,United Kingdom ,Italy ,Rome ,Lazio ,United States ,Canadian ,British ,American ,Marvins Hausman ,Derek Ivany ,William Rascan ,Health Canada ,Twitter ,Canadian Securities Exchange ,Science Inc ,University Of Central Florida ,Facebook ,European Union ,Research Foundation ,Instagram ,Us Drug Enforcement Administration ,Nova Mentis Life Science Corp ,Viviana Trezza At Rome Tre University ,British Columbia Newsfile Corp ,Toronto Institute Of Pharmaceutical Technology ,Neither The Canadian Securities Exchange ,Mentis Life Science ,Orphan Drug ,Viviana Trezza ,Rome Tre University ,American Observational ,Therapeutic Index ,Toronto Institute ,Pharmaceutical Technology ,Enforcement Administration ,Central Florida ,Controlled Drugs ,Substances Act ,Market Regulator ,Nova ,Eventis ,Life ,Science ,Orp ,Rovides ,Corporate ,Update ,023 ,Outlook ,